SHORT LEVERAGE - ASTRAZENECA Stock

Certificat

72K5S

DE000SV4KG58

Market Closed - Euronext Paris 10:59:16 2024-01-24 EST
1.2 ^EUR	+0.25%

1 month	+2.21%
3 months	+3.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ASTRAZENECA PLC

Latest news about ASTRAZENECA PLC

Combination treatment could provide new standard-of-care for aggressive lymphoma	05-03	AQ
AI Startup Fileread Names Former AstraZeneca Legal Leader as Chief Strategy Officer and General Counsel to Drive Product Development and Accelerate Growth	05-03	AQ
Angle shares up on assay development deal with AstraZeneca	05-03	AN
Astrazeneca - CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial	05-03	AQ

More news

Static data

Product type	Exotic Products
Buy / Sell	PUT
Underlying	ASTRAZENECA PLC
Issuer	Société Générale
	72K5S
ISIN	DE000SV4KG58
Date issued	2023-04-21
Maturity	Unlimited
Parity	1 : 1
Emission price	1 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.246 €
Lowest since issue	0.967 €

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

More about the company